XENO BIOSCIENCES

Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. It was founded in 2015 and is headquartered in Somerville, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

XENO BIOSCIENCES

Social Links:

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2015-01-01

Address:

Somerville, Massachusetts, United States

Country:

United States

Website Url:

http://www.xenobiosciences.com

Total Employee:

Status:

Active

Contact:

714-715-0970

Total Funding:

7.25 M USD

Technology used in webpage:

Viewport Meta SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Google Apps For Business Typekit

Similar Organizations

arcellx-logo

Current Advisors List

stan-rose_image

Stan Rose Board Member @ Xeno Biosciences
Board_member

Current Employees Featured

not_available_image

David Beno
David Beno Chief Executive Officer @ Xeno Biosciences
Chief Executive Officer

not_available_image

Dr. Hasan Celiker
Dr. Hasan Celiker Founder & Advisor @ Xeno Biosciences
Founder & Advisor

Founder

not_available_image

Dr. Hasan Celiker

Investors List

cr-ventures_image

Official Site Inspections

http://www.xenobiosciences.com Semrush global rank: 6 M Semrush visits lastest month: 1.36 K

Host Informations
Whois Informations

Loading ...